Table IV.
Multi-criteria analysis using the ordinal MAGIQ method.
| Effectiveness | Risk of Adverse Effects. | Cost | |||||
|---|---|---|---|---|---|---|---|
| Priority #1, weight 0.61 |
Priority #2, weight 0.28 |
Priority #3, weight 0.15 |
|||||
|
Symptom relief |
Halt disease progression |
Serious | Common | ||||
| Intra-criterion priority |
#2, weight 0.25 |
#1, weight 0.75 |
# 1, weight 0.75 |
#2, weight 0.25 |
|||
| Global decision priority |
0.61 × 0.25 = 0.15 |
0.61 × 0.75 = 0.46 |
0.28 × 0.75 = 0.21 |
0.28 × 0.25 = 0.07 |
0.15 × 1 = 0.15 |
Summary Scores a | |
| Alternative ranks and scores | Raw | Normalized | |||||
| Drug A | #1 - 0.61 | #3 – 0.15 | #1 – 0.61 | #1 – 0.61 | #1 – 0.61 | 0.42 | 0.39 |
| Drug B1 | #2 - 0.22 | #2 – 0.28 | #2 – 0.28 | #2 – 0.28 | #2 – 0.28 | 0.29 | 0.27 |
| Drug C | #3 - 0.15 | #1 – 0.61 | #3 – 0.15 | #3 – 0.15 | #3 – 0.15 | 0.37 | 0.34 |
a
Summary score calculated by multiplying alternative scores for each criterion times the criterion priorities and then normalizing by dividing each score the sum of scores. For example, the raw summary score of Drug A = (0.15 × 0.61) + (0.46 × 0.15) + (0.21 × 0.61) + ( 0.07 × 0.61) + (0.15 × 0.61); the normalized score = 0.42 / (0.42 + 0.29 + 0.37).